RIG-I antibody | knockout validation | Adipogen AG-20B-0009-C100

This is a knockout-validated antibody summary, based on the publication "The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Mouse monoclonal IgG1

Company: Adipogen

Antibody: RIG-I

Catalog number: AG-20B-0009-C100

Summary: Mouse monoclonal IgG1 against recombinant human RIG-I (aa 201-713). Reacts with human and mouse. Suitable for western blot, immunohistochemistry (paraffin), and immunoprecipitation.

Validation Method

Western blot

Sample

Control and RIG-I KO HaCaT cells.

Blocking agent

5% (wt/vol) nonfat dry milk in PBS-Tween 20 for 1 h.

Primary incubation

1:1,000 dilution either 1 h at room temperature or at 4°C overnight.

Secondary incubation

1:2,500 dilution secondary anti-mouse IgG-horseradish peroxidase (7076S; Cell Signaling) antibodies at room temperature for 1 h.

Detection

Protein bands were visualized with the enhanced SuperSignal West Pico chemiluminescence reagent (Thermo Fisher) and were detected by a luminescent imaging system (LAS-4000; Fuji).

Figure

Western blot of HaCaT cells expressing nontargeting control guide RNA (NT) or transduced with guide RNA targeting RIG-I (RIG-I KO). Actin served as a loading control. Please see Figure 5b in the article [1].

Clone note

The same clone (Alme-1) is sold as LifeSpan Biosciences LS-C344741, LS-C344928; Abnova MAB16084; Adipogen AG-20B-0009-C100.

References
  1. Chiang C, Pauli E, Biryukov J, Feister K, Meng M, White E, et al. The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling. J Virol. 2018;92: pubmed publisher